화학공학소재연구정보센터
Macromolecular Research, Vol.19, No.2, 180-188, February, 2011
Self-Assembled Nanogel of Pluronic-Conjugated Heparin as a Versatile Drug Nanocarrier
E-mail:
Heparin has not been used as a macromolecule to prepare nanocarriers for drug delivery, even though it has advantageous structural features, such as a negatively charged structure and presence of specific binding domains of proteins. In this study, a nanogel of a Pluronic-conjugated heparin was prepared by direct dissolution to develop a versatile drug nanocarrier composed of heparin. The aqueous nanogel solution of the heparin-Pluronic (HP) conjugate, exhibited higher stability than the micelles and smaller hydrodynamic size than 100 nm. The drug encapsulation test demonstrated that the HP nanogel encapsulates efficiently both hydrophobic small molecules and proteins. The release profile of indomethacin (IMC) was almost zero-order without a burst due to the presence of heparin, which appears to be advantageous comparing to polymeric micelles. Circular dichroism (CD) and gel electrophoresis demonstrated that the stability of monoclonal antibodies (3D8 scFv) encapsulated into the HP nanogel had been maintained. Overall, the self-assembled HP nanogel may be a versatile and promising nanocarrier for a range of drugs in drug delivery applications.
  1. Brannon-Peppas L, Blanchette JO, Adv. Drug Deliv. Rev., 56, 1649 (2004)
  2. Capila I, Linhardt RJ, Angew. Chem.-Int. Edit., 41, 390 (2002)
  3. Jayson GC, Gallagher JT, Br. J. Cancer, 75, 9 (1997)
  4. Fatma N, Singh DP, Shinobara T, Chylack LT, Invest. Ophthalmol. Vis. Sci., 41, 2648 (2000)
  5. Oh JK, Drumright R, Siegwart DJ, Matyjaszewski K, Prog. Polym. Sci, 33, 448 (2008)
  6. Nayak S, Lyon LA, Angew. Chem.-Int. Edit., 44, 7686 (2005)
  7. Kabanov AV, Vinogradov SV, Angew. Chem.-Int. Edit., 48, 5418 (2009)
  8. Rapoport N, Colloids Surf. B: Biointerfaces, 16, 93 (1999)
  9. Minko T, Batrakova EV, Li S, Li Y, Pakunlu RI, Alakhov VY, Kabanov AV, J. Control. Release, 105, 269 (2005)
  10. Rapoport NY, Herron JN, Pitt WG, Pitina L, J. Control. Release, 58, 153 (1999)
  11. Batrakova EV, Kabanov AV, J. Control. Release, 130, 98 (2008)
  12. Go DH, Joung YK, Park SY, Park YD, Park KD, J. Biomed. Mater. Res., 86A, 842 (2008)
  13. Jee KS, Dal Park H, Park KD, Ha Kim Y, Shin JW, Biomacromolecules, 5(5), 1877 (2004)
  14. Lee JS, Go DH, Bae JW, Lee SJ, Park KD, J. Control. Release, 117, 204 (2007)
  15. Smith PK, Mallia AK, Hermanson GT, Anal. Biochem., 109, 466 (1980)
  16. Park KD, Okano T, Nojiri C, Kim SW, J. Biomed. Mater. Res., 22, 977 (1988)
  17. Lee Y, Moon HT, Byun Y, Thromb. Res., 92, 149 (1998)
  18. Liu SQ, Tong YW, Yang YY, Biomaterials, 26, 5064 (2005)
  19. Allen C, Maysinger D, Eisenberg A, Colloids Surf. B: Biointerfaces, 16, 3 (1999)
  20. Joung YK, Choi JH, Park KM, Park KD, J. Biomed. Mater. Res., 2, 269 (2007)
  21. Joung YK, Lee JS, Park KD, Lee SJ, Macromol. Res., 16(1), 66 (2008)
  22. Al-Saden AA, Whateley TL, Florence AT, J. Colloid Interface Sci., 90, 303 (1982)
  23. Lee JS, Bae JW, Joung YK, Lee SJ, Han DK, Park KD, Int. J. Pharm., 346, 57 (2008)
  24. Park KM, Bae JW, Joung YK, Shin JW, Park KD, Colloids Surf. B: Biointerfaces, 63, 1 (2008)
  25. Daugherty A, Mrsny RJ, Adv. Drug Deliv. Rev., 58, 686 (2006)
  26. Kim YR, Kim JS, Lee SH, Lee WR, Sohn JN, Chung YC, Shim HK, Lee SC, Kwon MH, Kim YS, J. Biol. Chem., 284, 15287 (2006)
  27. Choi WS, Bae JW, Lim HR, Kwon IK, Joung YK, Park JC, Park KD, Macromol. Res., 16, 42 (2009)
  28. Park KD, Park HD, Lee HJ, Kim YH, Ooya T, Yui N, Macromol. Res., 12(4), 342 (2004)
  29. Park HD, Bae JW, Park KD, Ooya T, Yui N, Jang JH, Han DK, Shin JW, Macromol. Res., 14(1), 73 (2006)
  30. Son S, Lee WR, Joung YK, Kwon MH, Kim YS, Park KD, Int. J. Pharm., 368, 178 (2009)